Mast cells are key mediators in the cathelicidin inflammatory pathway in rosacea, particularly through their role in amplifying the neuroinflammatory response via the upregulation of the antimicrobial peptide LL-37, which plays a central role in the pathophysiology of all rosacea subtypes [94]. Here, CAMP is linked to rosacea.